Sanofi aims for immunology leadership with strong Dupixent sales By Investing.com
© Reuters.
In a recent earnings call at the 42nd J.P. Morgan Healthcare Conference, Sanofi (NASDAQ:)'s CEO Paul Hudson (NYSE:) outlined the company's robust strategy and performance, particularly emphasizing its focus on becoming…